Company / EPS (Diluted)
PULSE BIOSCIENCES, INC. EPS (Diluted) History
FY2021-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.26
FY2021
5-year range
-$2.26 / -$2.26
FY2021-FY2021
Trend
-
vs FY2020
Sector context
#137 of 159
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s eps (diluted) of $-2.26 is lower than 86% of companies in the Health Care sector (FY2021).
Based on SEC 10-K filings.
-2.26 in FY2021.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 159This company -$2.26 Sector average $1.67
▼
-235.5% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$2.26 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026